Vanda Pharmaceuticals (NASDAQ:VNDA) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Get Rating) in a research note published on Thursday. The firm issued a strong-buy rating on the biopharmaceutical company’s stock. Vanda Pharmaceuticals Stock Down 1.6 % Shares of VNDA opened at $6.11 on Thursday. The company has a 50-day simple moving average of $6.53 and […]

Related Keywords

Joakim Wijkstrom ,Timothy Williams ,Pricet Rowe Associates Inc ,Vanda Pharmaceuticals Stock Down ,Financial Services Group Inc ,News Ratings For Vanda Pharmaceuticals Daily ,Capital Advisors Ltd ,Ghost Tree Capital ,Hedge Funds Weigh In On Vanda Pharmaceuticals ,Securities Exchange Commission ,Vanda Pharmaceuticals ,Vanda Pharmaceuticals Inc ,Get Rating ,Pharmaceuticals Stock Down ,Exchange Commission ,Services Group ,Vanda Pharmaceuticals Daily ,Nasdaq Vnda ,Vnda ,Medical ,92165910 ,Initiated Coverage ,Stocknews Com ,